Severe myelosuppression resulting from concurrent administration of granulocyte colony-stimulating factor and cytotoxic chemotherapy
- PMID: 1378905
- DOI: 10.1093/jnci/84.15.1201
Severe myelosuppression resulting from concurrent administration of granulocyte colony-stimulating factor and cytotoxic chemotherapy
Similar articles
-
[Paradoxical myelosuppression with granulocyte-stimulating factor (G-CSF) and simultaneous administration chemotherapy].Med Clin (Barc). 1993 Sep 11;101(7):276. Med Clin (Barc). 1993. PMID: 7538188 Spanish. No abstract available.
-
Granulocyte colony-stimulating factor: effective in ameliorating fluorouracil-based myelosuppression?J Natl Cancer Inst. 1993 May 19;85(10):826-7. doi: 10.1093/jnci/85.10.826. J Natl Cancer Inst. 1993. PMID: 7683729 Clinical Trial. No abstract available.
-
Biochemical modulation in the treatment of advanced cancer: a study of combined leucovorin, fluorouracil, and iododeoxyuridine.Clin Cancer Res. 1996 Sep;2(9):1475-80. Clin Cancer Res. 1996. PMID: 9816323
-
[Persistent granulocytosis and hyperuricemia after a single G-CSF injection (Filgrastim) in treatment of chemotherapy-induced myelosuppression in metastatic breast carcinoma].Zentralbl Gynakol. 1995;117(6):314-6. Zentralbl Gynakol. 1995. PMID: 7544054 German.
-
Overview of current status and future direction of clinical trials with 5-fluorouracil in combination with folinic acid.Cancer Treat Rep. 1987 Dec;71(12):1249-64. Cancer Treat Rep. 1987. PMID: 3319136 Review. No abstract available.
Cited by
-
Effect of concomitant use of G-CSF and myelosuppressive chemotherapy on bone marrow and peripheral granulocytes in a mouse model.Med Oncol. 2022 Jun 6;39(8):110. doi: 10.1007/s12032-022-01725-9. Med Oncol. 2022. PMID: 35666320
-
Co-administration of dexamethasone increases severity and accelerates onset day of neutropenia in bladder cancer patients on methotrexate, vinblastine, adriamycin and cisplatin chemotherapy: a retrospective cohort study.J Pharm Health Care Sci. 2017 Jan 11;3:3. doi: 10.1186/s40780-016-0072-5. eCollection 2017. J Pharm Health Care Sci. 2017. PMID: 28097015 Free PMC article.
-
Patient, nurse, and physician preferences: final results of the CONVENIENCE study evaluating pegfilgrastim prophylaxis via pre-filled syringe or on-body injector in cancer patients.Support Care Cancer. 2021 Nov;29(11):6633-6643. doi: 10.1007/s00520-021-06230-9. Epub 2021 May 6. Support Care Cancer. 2021. PMID: 33956213 Free PMC article. Clinical Trial.
-
Safety and Efficacy of Same-Day Administration of Pegfilgrastim in Patients Receiving Chemotherapy for Gastrointestinal Malignancies.Cancer Med J. 2021 Apr 1;4(1):6-11. Epub 2020 May 18. Cancer Med J. 2021. PMID: 32656544 Free PMC article.
-
Optimizing the effectiveness of hematopoietic growth factors.J Clin Immunol. 1994 Jul;14(4):215-23. doi: 10.1007/BF01552307. J Clin Immunol. 1994. PMID: 7523435 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical